AKT1 and familial dilated cardiomyopathy: In the current study, CEPO increased PI3K (p85α) and Akt1 mRNA expression levels, and also enhanced p-PI3K (p85) and p-Akt (Ser/Thr) protein expression levels in the hearts of rats with DCM, in a dose-dependent manner.